Role of re-resection in non-muscle-invasive bladder cancer. Review uri icon

Overview

abstract

  • Restaging, or second transurethral resection (TUR), is essential to successful management of high-risk, non-muscle-invasive bladder cancer. Here we review the relevant literature documenting the role of restaging TUR. Cohort and randomized studies show that restaging TUR detects more tumors than initial TUR, improves clinical staging, and reduces the frequency of early tumor recurrences. Our conclusions show thatrestaging TUR improves the outcomes of high-risk,non-muscle-invasive bladder neoplasms.

publication date

  • February 3, 2011

Research

keywords

  • Neoplasm Staging
  • Urinary Bladder Neoplasms

Identity

PubMed Central ID

  • PMC5720095

Scopus Document Identifier

  • 79952407187

Digital Object Identifier (DOI)

  • 10.1100/tsw.2011.29

PubMed ID

  • 21298219

Additional Document Info

volume

  • 11